Patent · US Active

Expandable drug delivery devices and methods of use

US11110001B2 · kind B2 · utility

1Cited by
191References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 1, 2019
Grant dateSep 7, 2021
Priority date
Expiry dateNov 7, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2250/0069
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described are implantable devices having expandable reservoirs for the sustained release of therapeutic agents. The device is configured to be at least partially implanted in an eye and includes a retention structure and a penetrable element coupled to and extending within at least a portion of the retention structure. A porous drug release mechanism is positioned in fluid communication with an outlet of the device; and a reservoir having a volume configured to contain one or more therapeutic agents is in fluid communication with the outlet through the porous drug release mechanism. The device is at least partially inserted along an axis of insertion. The reservoir enlarges from an insertion configuration having a first three-dimensional shape to an expanded configuration having a second three-dimensional shape, the second three-dimensional shape being eccentrically positioned relative to the axis of insertion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.